<div id="readability-page-1">01:59 PM EST, 12/26/2025 (MT Newswires) -- Health care stocks declined Friday afternoon, with the NYSE Health Care Index and the State Street Health Care Select Sector SPDR ETF (XLV) each shedding 0.2%.The iShares Biotechnology ETF (IBB) decreased 0.8%.In corporate news, Johnson &amp; Johnson ( JNJ ) shares were down 0.4% after the company said Friday that a phase 2b trial assessing JNJ-95475939 in moderate to severe atopic dermatitis was terminated early after interim analysis showed that it did not meet the target efficacy.Eli Lilly ( LLY ) will pay a $40 million upfront payment and a $15 million equity investment to ABL Bio, the latter said Friday. The upfront payment of $40 million is for the license, research, and collaboration agreement for ABL's Grabody platform, ABL said, adding that the two parties are carrying out joint research and development on multiple therapeutic candidates. Eli Lilly ( LLY ) shares decreased 0.2%.Can-Fite BioPharma ( CANF ) shares jumped 20% after receiving a patent from the Brazilian Patent Office for its A3 adenosine receptor, or A3AR, drugs to treat sexual dysfunction. MT Newswires does not provide investment advice. Unauthorized reproduction is strictly prohibited.</div>

强生

CANF

礼来

医疗保健股票在周五下午下跌，纽约证券交易所医疗保健指数和 XLV ETF 下跌 0.2%，IBB ETF 下跌 0.8%。强生的股票在一项审判被终止后下跌 0.4%。礼来的股票在与 ABL Bio 达成 4000 万美元交易后下跌 0.2%。Can-Fite BioPharma 的股票在巴西获得专利批准后上涨 20%

板块更新：周五下午交易时段，医疗保健类股走低